The $5,154 Patient: A Digital Shift Rewrites Surgical Economics

TAMPA, FL – June 15, 2026 – A new report is sending tremors through the healthcare industry, quantifying the immense value of intervening not at the point of care, but at the point of decision. Paradigm, a specialty care management organization, has released compelling data on its My Surgery program, showing an average annual savings of $5,154 per participant. This isn't just another incremental improvement; it's a flashing signal that the very architecture of managing surgical costs is being fundamentally rewritten, shifting power from reactive administrative processes to proactive, data-driven patient engagement.

The report, which analyzed outcomes for over 50,000 members, demonstrates a 6.8-to-1 return on investment for health plans. These are not soft figures; they are the result of a rigorous statistical analysis and point to a powerful new engine for value in the notoriously inefficient U.S. healthcare system. The findings suggest that the most effective way to manage costs isn't to build higher walls around procedures, but to build better pathways to informed decisions for patients.

The Anatomy of a Hidden Cost

At the heart of this transformation is a category of procedures known as preference-sensitive surgeries. These are common, often costly operations—like certain spinal surgeries or knee replacements—for which viable non-surgical alternatives exist. The 'right' choice is not always clear-cut and depends heavily on a patient’s specific clinical profile, risk factors, and personal goals. According to industry analyses, these procedures quietly account for an average of 30% of a health plan's total medical spend. For years, this has been a massive, unmanaged leak in the system, with costs scattered across specialties and rarely aggregated in a way that reveals their true financial weight.

The traditional toolkit for containing these costs has been dominated by downstream interventions. Tactics like prior authorization, clinical reviews, and network management engage the patient only after they—and their physician—have largely committed to a surgical path. This creates an adversarial dynamic and often comes too late to meaningfully influence the care journey.

“For too long, the healthcare industry has approached surgical decision-making too late in the process, after patients have already committed to a procedure,” said John S. Watts, Jr., CEO of Paradigm, in a statement accompanying the report. The data now suggests that this reactive posture is not just inefficient, but economically inferior.

Deconstructing the Digital Intervention

Paradigm's My Surgery program, which builds upon the foundation of the Welvie platform acquired by the company in 2023, represents the 'upstream' model. Instead of acting as a gatekeeper, the digital platform functions as a guide. It engages members considering a preference-sensitive surgery, educating them about their condition, treatment options, personalized surgical risks, and what to expect from recovery. The goal is to elevate a patient's health literacy so they can have a more meaningful collaboration with their provider.

To validate its impact, the company employed a difference-in-differences methodology, a quasi-experimental technique considered an industry standard for real-world program evaluation. Researchers compared My Surgery users against a propensity-matched control group of non-participants, tracking outcomes for six months before and after the intervention to isolate the program's direct effects. This robust statistical approach lends significant credibility to the findings.

The results are striking. The program led to 116 fewer surgeries for every 1,000 participants, demonstrating that when patients are fully informed, a significant number will opt for less invasive alternatives. This surgery avoidance accounted for 36% of the total savings, or $1,868 per participant.

Even more telling is where the other 64% of savings ($3,286 per participant) came from: surgical outcomes optimization. For patients who did choose surgery, the program's pre-operative preparation and post-operative guidance led to dramatically better outcomes. The data shows 184 fewer emergency room visits, 884 fewer inpatient days, 82 fewer cases of sepsis, and 23 fewer surgical site complications per 1,000 participants. This proves the value extends far beyond the initial decision, creating a healthier, less costly recovery journey.

“There is a significant — and often overlooked — opportunity to impact utilization through upstream member decision-making support,” noted Nicola Merryman, SVP of Healthcare Solutions at Paradigm. “This level of education improves their health literacy and empowers them to utilize those skills in any care situation or setting.”

Reshaping the Healthcare Value Chain

The implications of this upstream shift extend across the entire healthcare ecosystem. For health plans, it offers a new, more effective lever for cost management that also improves member satisfaction. The model is particularly potent for government-sponsored plans, with the report finding annual savings of $5,764 per participant in Medicare populations. As market pressures intensify, health plans that successfully transition from adversarial utilization management to collaborative decision support will gain a significant competitive advantage.

This trend is already gaining market traction. Paradigm's recent acquisition by healthcare investment firm Patient Square Capital and its My Surgery program's recognition as the "Best Patient Education Solution" in the 2026 MedTech Breakthrough Awards signal strong investor and industry confidence in this value-based model. Over 1.5 million people have used the program, with an impressive 30% ultimately changing their treatment decision after becoming more informed.

For providers, these tools can foster a more collaborative and efficient clinical environment. A more educated patient arrives at a consultation prepared for a substantive discussion, not just to receive a directive. This aligns with the broader move toward shared decision-making as a standard of care, turning the patient into a true partner in their own health journey.

The Governance of Digital Guidance

As this digital infrastructure becomes more integrated into healthcare, it brings a new set of responsibilities and regulatory considerations. Platforms like My Surgery operate at the intersection of data science and patient care, making governance a critical component of their long-term success. As they handle sensitive personal health information, strict adherence to HIPAA and other data privacy laws is non-negotiable.

Furthermore, because these tools provide information that can influence major medical decisions, they may fall under the purview of the FDA's framework for Software as a Medical Device (SaMD). This requires rigorous validation and a commitment to transparency in how the software arrives at its personalized guidance.

The most crucial challenge, however, is ethical. There is a fine line between informing a patient and persuading them. The design of these platforms must be meticulously audited to ensure they present information in a balanced, unbiased way. The algorithms that personalize risk must be trained on diverse data sets to avoid perpetuating health disparities. The ultimate success of this digital transformation in healthcare will hinge not just on the cost savings it generates, but on the trust it builds with every patient it guides.